Montelukast Prescribing at VERULAM MEDICAL GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
323
Total Quantity
10.4K
NHS Cost
£545
vs National Avg
-52.8%
VERULAM MEDICAL GROUP prescribed 323 items of Montelukast over the last 12 months at a cost of £545 to the NHS. This is 52.8% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
30
Jun 2026
24
Jun 2026
29
Jun 2026
27
Jun 2026
25
Jun 2026
28
Jun 2026
27
Jun 2026
26
Jun 2026
34
Jun 2026
28
Jun 2026
20
Jun 2026
25
Prescribing Details
| Total Items | 323 |
|---|---|
| Total Quantity | 10,353 |
| Total NHS Cost | £545 |
| Presentations | 4 different forms |
| vs National Average | -52.8% |
Montelukast Prescribing Comparison
| This practice | 323 items |
|---|---|
| National average per practice | 685 items |
| Difference | -52.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.